Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Endoscopic Retrograde Cholangiopancreatography Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Endoscopic Retrograde Cholangiopancreatography Trends and Forecast

The future of the global endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets. The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.
Endoscopic Retrograde Cholangiopancreatography Market by Product, Procedure, and End Use

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Endoscopic Retrograde Cholangiopancreatography Market by Segments

Endoscopic Retrograde Cholangiopancreatography by Segment

The study includes a forecast for the global endoscopic retrograde cholangiopancreatography by product, procedure, end use, and region.

Endoscopic Retrograde Cholangiopancreatography Market by Product [Shipment Analysis by Value from 2018 to 2030]:


• Endoscopes
• Endotherapy Devices
• Visualization Systems
• Energy Devices
• Others

Endoscopic Retrograde Cholangiopancreatography Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:


• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dialtation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation

Endoscopic Retrograde Cholangiopancreatography Market by End Use [Shipment Analysis by Value from 2018 to 2030]:


• Hospitals
• Ambulatory Surgery Centers & Clinics
• Other

Endoscopic Retrograde Cholangiopancreatography Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Endoscopic Retrograde Cholangiopancreatography Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endoscopic retrograde cholangiopancreatography companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscopic retrograde cholangiopancreatography companies profiled in this report include-
• Hobbs Medical
• STERIS
• Merit Medical Systems
• TeleMed Systems
• Changzhou Health Microport Medical Device

Endoscopic Retrograde Cholangiopancreatography Market Insights

Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.
Within this market, hospital will remain the largest segment due to availability of wide range of ERCP devices in these facilities.
North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.

Features of the Global Endoscopic Retrograde Cholangiopancreatography Market

Market Size Estimates: Endoscopic retrograde cholangiopancreatography market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Endoscopic retrograde cholangiopancreatography market size by product, procedure, end use, and region in terms of value ($B).
Regional Analysis: Endoscopic retrograde cholangiopancreatography market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, procedures, end uses, and regions for the endoscopic retrograde cholangiopancreatography market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscopic retrograde cholangiopancreatography market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the endoscopic retrograde cholangiopancreatography market size?
Answer: The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030.
Q2. What is the growth forecast for endoscopic retrograde cholangiopancreatography market?
Answer: The global endoscopic retrograde cholangiopancreatography market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the endoscopic retrograde cholangiopancreatography market?
Answer: The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.
Q4. What are the major segments for endoscopic retrograde cholangiopancreatography market?
Answer: The future of the endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets.
Q5. Who are the key endoscopic retrograde cholangiopancreatography market companies?
Answer: Some of the key endoscopic retrograde cholangiopancreatography companies are as follows:
• Hobbs Medical
• STERIS
• Merit Medical Systems
• TeleMed Systems
• Changzhou Health Microport Medical Device
Q6. Which endoscopic retrograde cholangiopancreatography market segment will be the largest in future?
Answer: Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.
Q7. In endoscopic retrograde cholangiopancreatography market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the endoscopic retrograde cholangiopancreatography market by product (endoscopes, endotherapy devices, visualization systems, energy devices, and others), procedure (biliary sphincterotomy, biliary stenting, biliary dialtation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation), end use (hospitals, ambulatory surgery centers & clinics, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Endoscopic Retrograde Cholangiopancreatography Market, Endoscopic Retrograde Cholangiopancreatography Market Size, Endoscopic Retrograde Cholangiopancreatography Market Growth, Endoscopic Retrograde Cholangiopancreatography Market Analysis, Endoscopic Retrograde Cholangiopancreatography Market Report, Endoscopic Retrograde Cholangiopancreatography Market Share, Endoscopic Retrograde Cholangiopancreatography Market Trends, Endoscopic Retrograde Cholangiopancreatography Market Forecast, Endoscopic Retrograde Cholangiopancreatography Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Endoscopic Retrograde Cholangiopancreatography Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Endoscopic Retrograde Cholangiopancreatography Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Endoscopic Retrograde Cholangiopancreatography Market by Product
3.3.1: Endoscopes
3.3.2: Endotherapy Devices
3.3.3: Visualization Systems
3.3.4: Energy Devices
3.3.5: Others
3.4: Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
3.4.1: Biliary Sphincterotomy
3.4.2: Biliary Stenting
3.4.3: Biliary Dialtation
3.4.4: Pancreatic Sphincterotomy
3.4.5: Pancreatic Duct Stenting
3.4.6: Pancreatic Duct Dilatation
3.5: Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
3.5.1: Hospitals
3.5.2: Ambulatory Surgery Centers & Clinics
3.5.3: Other
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Endoscopic Retrograde Cholangiopancreatography Market by Region
4.2: North American Endoscopic Retrograde Cholangiopancreatography Market
4.2.1: North American Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
4.2.2: North American Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
4.3: European Endoscopic Retrograde Cholangiopancreatography Market
4.3.1: European Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
4.3.2: European Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
4.4: APAC Endoscopic Retrograde Cholangiopancreatography Market
4.4.1: APAC Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
4.4.2: APAC Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
4.5: ROW Endoscopic Retrograde Cholangiopancreatography Market
4.5.1: ROW Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
4.5.2: ROW Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Product
6.1.2: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
6.1.3: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
6.1.4: Growth Opportunities for the Global Endoscopic Retrograde Cholangiopancreatography Market by Region
6.2: Emerging Trends in the Global Endoscopic Retrograde Cholangiopancreatography Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Endoscopic Retrograde Cholangiopancreatography Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endoscopic Retrograde Cholangiopancreatography Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Hobbs Medical
7.2: STERIS
7.3: Merit Medical Systems
7.4: TeleMed Systems
7.5: Changzhou Health Microport Medical Device
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Endoscopic Retrograde Cholangiopancreatography Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.